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Abstract: The basal ganglia (BG) are a collection of interconnected subcortical nuclei that participate in
a great variety of functions, ranging from motor programming and execution to procedural learning,
cognition, and emotions. This network is also the region primarily affected by the degeneration of
midbrain dopaminergic neurons localized in the substantia nigra pars compacta (SNc). This degeneration
causes cellular and synaptic dysfunctions in the BG network, which are responsible for the appearance
of the motor symptoms of Parkinson’s disease. Dopamine (DA) modulation and the consequences of
its loss on the striatal microcircuit have been extensively studied, and because of the discrete nature
of DA innervation of other BG nuclei, its action outside the striatum has been considered negligible.
However, there is a growing body of evidence supporting functional extrastriatal DA modulation of
both cellular excitability and synaptic transmission. In this review, the functional relevance of DA
modulation outside the striatum in both normal and pathological conditions will be discussed.
Keywords: Globus pallidus; subthalamic nucleus; substantia nigra; dopamine; pacemaking; neuronal
excitability; GABAergic transmission; neuronal oscillations
1. Introduction
The basal ganglia (BG) participate in a great variety of functions including motor programming
and execution, procedural learning, cognition, and emotions [1,2]. Dopaminergic innervation provided
by mesencephalic dopamine (DA) neurons from the substantia nigra pars compacta (SNc) plays an
essential role in the control of BG functions by modulating cellular and synaptic properties at each
stage of the BG network. DA modulation of the striatal microcircuit has been extensively studied over
the past decades and has been instrumental to better understand striatal function in health and disease
states (for reviews, see [3,4]). The degeneration of midbrain DA neurons and the subsequent loss of
DA in the BG trigger cellular and synaptic alterations, which are believed to be responsible for the
appearance of the motor symptoms of Parkinson’s disease (PD). Dopaminergic innervation of the
striatum (STR) is acknowledged to be by far denser than in the rest of the BG. Nevertheless, there is a
growing body of evidences supporting the existence of discrete, functional dopaminergic innervation of
extra-striatal nuclei (ESN), namely the subthalamic nucleus (STN), the internal and external segments
of the globus pallidus (GPi and GPe, respectively) and the substantia nigra pars reticulata (SNr) [5]. In
line with this evidence, the action exerted by DA on ESN has been investigated only recently and
is the focus of the present review. After a brief description of BG network organization, we will
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discuss recent discoveries supporting a functional role of DA outside the striatum in both healthy and
disease conditions.
The STR is the main entry structure of the BG and the principal recipient of cortical inputs. This
GABAergic nucleus consists of 95% projection neurons, recognizable by their small soma and their
dendrites covered by spines—therefore called spiny projection neurons (SPN). The remaining 5%
of the STR is composed of several classes of GABAergic and cholinergic interneurons [6,7]. SPNs
give rise to two pathways that propagate cortical information directly or indirectly to the output of
the BG. SPNs of the direct pathway (dSPNs) express dopamine D1 receptors (D1Rs) and primarily
innervate BG output neurons of the SNr and GPi (called the entopeduncular nucleus in rodents,
EPN) in a monosynaptic manner. On the other hand, SPNs of the indirect pathway (iSPNs) express
dopamine D2 receptors (D2Rs) and project to BG outputs via a polysynaptic route involving the GPe
(called the globus pallidus in rodents, GP) and the STN. As predicted by the anatomical-functional
model of the BG [8], it has been shown experimentally that these two pathways exert opposite
control over motor execution [9] (Figure 1). However, this view of opposite functions of the direct
and the indirect pathways has been challenged by a study showing that both iSPNs and dSPNs are
co-activated before movement initiation [10]. This coordinated activity has been interpreted as dSPN
activation representing a process of selection/activation of a desired movement, while simultaneously
activating iSPNs provides global suppression of alternative/unwanted actions [11]. In addition to these
two pathways, multiple loops within the BG network, such as the hyperdirect cortico-subthalamic
pathway [12], the reciprocally-connected GP-STN loop [13], the pallido-striatal pathway [14,15], and
bridging collaterals from dSPNs in the GP [16,17], certainly contribute to normal and pathological
operations of the BG network (Figure 1).
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The aim and scope of the present review are to provide a comprehensive overview of the current
literature regarding the role of DA in the modulation of ESN activity in both healthy conditions and
in PD.
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2. Extra-Striatal Nuclei Neurons Share Specific Features
2.1. ESN Neurons are Fast-Spiking Autonomous Pacemakers
A striking feature of ESN neurons compared to SPN is their ability to fire action potentials (APs)
in a completely autonomous manner (i.e., in absence of excitatory synaptic inputs). While several
voltage-dependent and voltage-independent conductances contribute to maintaining the membrane
potential of ESN neurons depolarized, persistent sodium and Kv3-family potassium channels appear to
play a critical role in the capability of GP, STN, EPN, and SNr neurons to perpetually fire APs at a high
rate [18–23]. Because of their very hyperpolarized potential [24,25], SPNs need to receive convergent
excitatory inputs to fire APs and convey information downwards through the BG network [26–29]. In
contrast, because ESN are autonomous pacemakers, their spiking activity is instead independent of
excitatory inputs [30]. Therefore, information encoding and transfer by these neurons relies more on
changes in their firing rate and pattern rather than on spiking activity per se.
2.2. GABAergic Transmission Efficiently Sculpts the Activity of ESN Neurons
Another interesting advantage of pacemaking for neurons is the emerging properties related
to AP timing relative to incoming afferent inputs [31–33]. Most of the ESN except for the STN, the
only glutamatergic nucleus of the network, are inhibitory nuclei. Therefore, GABAergic transmission,
through the activation of ionotropic GABAA and metabotropic GABAB receptors, is certainly the most
efficient system to control the firing of neurons and induces profound changes in their firing rate and
pattern [34,35]. Hyperpolarization of the membrane potential resets ESN neuron pacemaking activity
and engages voltage-gated channels. Activation or deactivation of those channels will transiently
modify the intrinsic excitability of ESN neurons following the inhibition [21,36–38], leading to complex
sequences of activity. These interactions between synaptic inhibitory inputs and voltage-gated channels
can contribute to the emergence of transiently correlated and synchronous activity within and among
the different nuclei, both in healthy and pathological states (see Section 7).
2.3. ESN Receive Functional Dopaminergic Innervation
In the brain, the STR is by far the principal recipient of dopaminergic inputs arising from the
SNc [39]. The dopaminergic modulation of the striatal microcircuit has been well characterized and is
the subject of many reviews [40,41], so it will not be covered here. Even if, in comparison, dopaminergic
innervation of the ESN can appear negligible compared to the STR, there are several lines of evidence
supporting functional extra-striatal dopaminergic innervation. Dopaminergic fibers and synapses
have been detected in the GP and the STN using light and electron microscopy [42–45]. DA release has
also been measured in the STN upon electrical stimulation of dopaminergic inputs using fast-scan
voltammetry [43]. In addition, DA receptors are expressed in all ESN (for a review, see [46]), and
local applications of dopaminergic receptor agonists and antagonists locally in various ESN affect the
neuronal activity of these nuclei [47–50]. All these data suggest that DA participates in the normal
function of the ESN by regulating both cellular excitability and synaptic transmission.
3. The Globus Pallidus
3.1. Neuronal Diversity in the GP
The GP has long been considered as a simple relay nucleus in the indirect pathway of the BG
despite anatomical/immunohistochemical and functional/electrophysiological studies suggesting a
certain degree of diversity in this nucleus [51–57]. More recent investigations have revealed the
molecular [58,59] and functional complexity [60–62] of the GP. Several cell types have been identified
based on the expression of specific molecular markers and electrophysiological properties [63–66].
Even if a unified nomenclature is still missing [67], two main clusters of neurons are emerging from
single-cell RNA profiling [59]. The first cluster is composed of the so-called prototypic GP neurons
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which project to downstream nuclei (the STN, the SNr, and the EPN) but also to the STR [63,68,69].
These neurons express the transcription factor (TF) Nkx2.1 and show a regular fast-spiking discharge
ex vivo [63,64]. This population represents more than 70% of the total number of neurons in the mouse
and the rat GP and include of a subgroup, representing approximately 34 of prototypic GP neurons,
which also express the calcium binding protein parvalbumin (PV) in addition to Nkx2.1 [63,70]. The
second cluster is made of arkypallidal GP neurons, which were described in the seminal study of Mallet
and colleagues [14]. This cell type, which represents between 15 to 28% of GP neurons depending on
the species studied [63,70], is characterized by the selective expression of the TF FoxP2 and a low and
irregular firing discharge. The main distinguishing feature of arkypallidal neurons is their exclusive
and massive axonal projections to the STR, which certainly constitutes the main external source of
GABA of this nucleus [14]. It is interesting to note here, that all arkypallidal neurons co-express the
TF NPas-1, but this marker is not specific to this neuronal population, as it is also found in a small
proportion of prototypic GP neurons [63,65,70].
The activity of prototypic and arkypallidal neurons has been characterized in vivo under anesthesia
both in the DA-intact (DI) and the DA-depleted (DD) rat [63,71]. In anesthetized rodents, prototypic
neurons are the population most affected by DD, with the appearance of pauses in their activity leading
to a reduced mean firing rate compared to the DI rat [63]. Several studies suggest that the emergence
of these pauses is due to an exaggerated drive from iSPNs [72–74], maybe because iSPN preferentially
send projections to prototypic neurons [75]. Together, these observations fit with the hypoactivity
of GP neurons predicted by the anatomo-functional model of the BG [8]. In contrast, arkypallidal
neuron activity seems less affected by DD, as only their phase-coupling increases without significantly
changing their firing rate or pattern [63]. These alterations in GP neuron activity in vivo can be due
either to changes in the intrinsic excitability and/or to changes in their afferent synaptic input drive
(discussed in Sections 3.4 and 3.5).
3.2. Ionic Conductances Underlying Pacemaking in GP Neurons
GP neurons exhibit a large range of firing activity and rates (between 0 to 100 Hz) in rodents and
non-human primates in vivo [57,76–78]. Recordings of GP neurons in dissociated neuron cultures and
in brain slices have demonstrated that this variability in firing is correlated with the type and density
of voltage-gated conductances expressed by individual GP neurons [53,79]. Despite these individual
differences, a subset of voltage-gated channels plays a key role in the autonomous pacemaking of
GP neurons. Repetitive emission of APs by GP neurons relies primarily on persistent sodium and
hyperpolarization-activated, cyclic nucleotide-gated cation (HCN) channels [21,80], which depolarize
the membrane potential at subthreshold potentials. The regularity and precision of GP neuron firing is
governed by both calcium-activated SK channels and HCN channels [81], while Kv3-family potassium
channels promote spike repolarization in these neurons, enabling high frequencies of discharges [22].
3.3. Dopamine Modulation of Intrinsic Excitability of GP Neurons
DA modulation of the excitability of GP neurons has been suggested by various techniques,
showing either the presence of dopaminergic fibers and receptors in the nucleus [42,44,82], the release
of DA [83–85], dopaminergic modulation of voltage-gated ion channels [86], and neuronal excitability
in vivo [87]. Interestingly, D2 receptor mRNA is present in all classes of pallidal neurons, with the
pallido-striatal neurons expressing higher levels of D2 transcripts than pallido-subthalamic cells [54,55].
This suggests a differential modulation by DA of prototypic and arkypallidal GP neurons. Thus, it
is likely that DD preferentially affects the intrinsic excitability of one population of GP neurons. DA
modulation of GP neuron excitability is poorly understood, and so far, only one study has shown a
direct action of DA on GP neuron voltage-gated conductance. In this study, the authors showed that
D2Rs inhibit CaV2.2 (N-type) channels in a protein kinase C (PKC)-dependent manner [86]. This result
suggests that D2R activation reduces GP neuron excitability (but see Section 4.1).
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Moreover, some GP neurons lose their autonomous pacemaking after DD [88]. The mechanism
underlying GP neuron pacemaking loss involves a CaV1.3 (L-type) calcium channel-dependent
downregulation of HCN2 channels [88]. It also seems that this alteration of excitability of GP neurons
preferentially affects NPas1-expressing pallido-striatal neurons. Indeed, the firing rate of the main
subpopulation of prototypic neurons, PV+ neurons, remains unaffected in DD mice [89]. As a
consequence, these results suggest that the change in the pattern of activity of PV+ GP neurons
observed in vivo [63,71] relies on changes in the activity of iSPNs. Indeed, the hyperactivity of iSPNs
promotes pauses in activity of prototypic cells [72–74]. It is interesting to note that, while excitability of
Npas1 GP neurons is reduced, the pallido-striatal GABAergic inhibition provided by these neurons is
increased in all subtypes of striatal neurons [89], suggesting the existence of a compensatory mechanism.
3.4. Dopamine Modulation of Gabaergic Transmission in the GP
GP neurons receive two main sources of GABA: extrinsic inputs coming from iSPNs and some
collaterals of dSPNs [16,17,90] and intrinsic inputs from local axon collaterals [91]. Striato-pallidal
inputs are mainly localized on proximal and distal dendrites of GP neurons [92], while pallido-pallidal
inhibitory synapses are found on the soma and proximal dendrites of GP neurons [91]. Regarding
their properties, striato-pallidal synapses are characterized by short-term facilitation (STF) [93,94] and
their strength is modulated by a plethora of G protein–coupled receptors (GPCR) [95–102] including
presynaptic D2Rs, which decrease the probability of GABA release [93,103]. In contrast, pallido-pallidal
synapses are characterized by short-term depression (STD) [93,94,104] and are not modulated by
presynaptic D2-like receptors [93]. GABAergic transmission is also regulated by postsynaptic D4Rs,
which reduce the amplitude of GABAA-mediated current through the suppression of protein kinase
A (PKA) activity [105]. The paired-pulse facilitation observed at striato-pallidal connection suggests
that this synapse has a low initial release probability. However, a full characterization of unitary
iSPN-GP connections will be required to better understand the release dynamics of these synapses. On
the other hand, paired-recordings of GP neurons have revealed that despite the sparse connectivity
(~1%; [91,104]) and STD, unitary pallido-pallidal transmission is able to reduce the postsynaptic firing
rate through a combination of chloride driving force, synaptic summation, and incomplete STD [104].
The sparse connectivity combined with the relative efficacy of axon local collaterals certainly contributes
to uncorrelated activity of GP neurons recorded in vivo under healthy conditions [78].
3.5. Astrocyte-Dependent Alteration of Gabaergic Inhibition in the GP
The GP is the nucleus in the BG with the highest astrocyte density [106], suggesting an important
role of these glial cells in regulating GP motor function. Indeed, voluntary exercise in mice triggers
astrocyte structural plasticity. This consists of elaboration of perisynaptic astrocyte processes (PAP) [107],
which are dynamic elements thought to regulate synaptic transmission by clearing neurotransmitter
and releasing gliotransmitter into the synaptic clefts [108–110]. GP astrocytes express GAT-3 GABA
transporters [111,112], which are primarily localized on PAPs [107]. They also express a variety of
ionotropic and GPCR receptors including DARs, suggesting that DA somehow modulates intracellular
signaling. Calcium imaging experiments have shown that D3R activation triggers a reduction in
intracellular Ca2+ waves under control conditions, while DD exerts the opposite effect [113]. We also
observed that DD is responsible for GP astrocytosis [106], which suggests astrocyte dysfunction in PD.
Two recent studies have elucidated distinct astrocyte signaling pathway impairments that promote
an increase in GABAergic transmission in the GP. In the first study, the authors demonstrated that
after DD, glutamate release from GP astrocyte is reduced, which dampens the activity of pre-synaptic
mGluR3 and in turn increases GABA release at striato-pallidal synapses (Figure 2) [113]. A second
study showed that DD also induces a reduction of the expression of GAT-3 in GP astrocytes, leading
to reduced uptake and elevation of ambient extracellular GABA levels promoting the activation of
extrasynaptic GABAAR-mediated tonic inhibition (Figure 2) [114]. Both astrocyte glutamate release
and GAT-3 uptake activity seem to be regulated by D2-like family receptors, suggesting that reduced
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stimulation of these receptors in DD conditions is responsible for the increase of extracellular GABA
concentrations [115] and GABAergic transmission in GP neurons. Overall, GP neuron hypoactivity
in vivo seems to be the consequence of several convergent mechanisms—at the circuit level, with
the hyperactivity of iSPNs [72,73], but also locally, with the reduction of GP excitability and the
dysregulation of GABAergic synaptic and extrasynaptic transmission [92,113,114] (Figure 4). Restoring
autonomous pacemaking in the GP by overexpression of HCN2 fails to re-establish motor function in
DD animals [88]. Interestingly, because GP astrocytes play a key role in the regulation of GABAergic
transmission, restoring normal levels of inhibition in the GP by manipulating astrocyte function
appears to be an attractive and promising therapeutic strategy to reduce PD motor symptoms.
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unknown mechanism, preventing GABA spillover from GABAergic synapses and hence activation of
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glutamate gliotransmission is reduced and mGluRIII-dependent reduction of GABA release is lost,
leading to an increase in striato-pallidal transmission. The loss of D2R modulation of GAT-3 triggers
a downregulation of the expression of the transporters, and the elevation of extracellular GABA
concentrations leads to the activation of extrasynaptic GABAA receptors, which favors tonic inhibition.
4. The Subthalamic Nucleus
4.1. Dopamine Modulation of STN Neuron Excitability
Because the change in the firing pattern of STN neurons is considered an electrophysiological
hallmark of PD, the modulation of the activity of STN neurons by DA has been the focus of many
studies. STN neurons mainly express D2/3Rs and D5Rs on their membrane [116,117]. Most of our
current knowledge about DA action on STN neurons comes from exogenous application of DA itself or
agonists of the D1- and D2-like receptor families in acute brain slices. Application of low concentrations
of DA or the D2-like receptor agonist quinpirole induces a depolarization of the membrane potential
and an increase in the spontaneous firing rate of STN neurons [43,116,118]. This excitatory action
of D2-like dopaminergic receptors is mediated by inhibition of CaV2.2 (N-type) calcium channel
currents by Gi/o βγ subunits. This inhibition reduces CaV2.2 channel functional coupling with
small-conductance Ca2+-dependent K+ (SKCa) channels, promotes membrane depolarization, and
increases firing discharge of STN neurons [116] (Figure 3A). On the other hand, D5R activation targets
several conductances depending on the mode of discharge of STN neurons [119]. When STN neurons’
membrane potential is hyperpolarized, they fire bursts of APs and D5R activation potentiates CaV1.3
calcium channel currents, prolonging burst duration [120] (Figure 3A). When STN neurons’ membrane
potential is depolarized, these neurons fire single APs in a tonic fashion, and D5R increases their firing
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rate via the activation of cyclic nucleotide gated non-cationic channels [121]. Therefore, it has been
proposed that D2Rs control the pattern of activity (tonic or burst) by setting the level of depolarization
of STN, while D5Rs reinforce each mode of discharge [118].
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4.2. Alteration of STN Autonomous Pacemaking in DA Depleted Rodents
It is widely accepted that the STN is hyperactive in PD and that STN neuron activity is composed
of rhythmic and synchronous bursts of APs [122]. This pathological activity can have several origins,
such as DA loss in the STN, leading to altered excitability of STN neurons or alterations in the BG
network. Ex vivo studies suggested that the excitability of STN neurons is strongly downregulated in
DD rodents [123,124], but the underlying mechanisms were unknown until recent work confirmed that
STN neuron autonomous pacemaking is lost in neurotoxic and genetic mouse models of PD [125]. This
loss of excitability seems to have a network origin, as it is triggered by the increased drive of iSPNs
onto GP neurons, leading to disinhibition of STN neurons and excessive activation of NMDAR, which
finally increases KATP channels [125]. Indeed, the expression of these channels has been reported to
be increased after DD [126], which produces sufficient hyperpolarization of the membrane potential
to silence STN neurons [125]. Another study suggests that DD alters the expression profile of HCN2
channels in the STN and also contributes to pathological activity in the BG in experimental PD [127].
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4.3. Augmentation of Pallido-Subthalamic Transmission in Experimental Parkinson’s Disease Models
The GP provides the STN’s principal source of GABA. Single GP axons make sparse clusters of
synaptic boutons distributed in distinct functional domains of the STN [128]. On average, a GP axon
makes at least six synaptic contacts on the soma and the proximal dendrites of STN neurons. Thus, each
GP neuron provides potent somatic inhibition, which is highly efficient to reset the autonomous activity
of STN neurons [128]. GP neurons fire APs at a high rate [70,129] and this elevated activity influences,
in an activity-dependent manner, the efficacy of GP-STN inputs that are characterized by STD [130,131].
GP-STN inputs are modulated by presynaptic D2/3Rs, which decrease the release probability of GABA
and thus reduce the strength of this connection. It is also interesting to note that DA converts GP-STN
synapses from low-pass filters to band-pass filters [131] favoring information transfer [132]. Under DD
conditions, GP-STN GABAergic transmission is greatly augmented due to structural modifications of
GP-STN synapses, which make more active zones per bouton [133] (Figure 3B). Recently, Chu and
colleagues [134] have unraveled the mechanisms underlying this proliferation of GABAergic synapses.
In this study, they showed that GABAergic long term potentiation (LTP) involves the excessive
activation of NMDA receptors, which triggers 1) nitric oxide synthesis and release by STN neurons,
which activates presynaptic protein kinase G (PKG) and increases GABA release probability, and 2)
an increase in intracellular Ca2+ concentrations that activate a CaMKIIα pathway, which augments
GABAA receptor insertion on the post-synaptic side of GABAergic GP-STN synapses [134] (Figure 3B).
4.4. Loss of the Cortico-Subthalamic Pathway in Experimental Parkinson’s Disease Models
The cortico-subthalamic (Cx-STN) projection is well described anatomically. Cx-STN synapses
are mainly found on the distal part of STN neurons’ dendrites [135,136]. The functional properties of
Cx-STN glutamatergic synapses have been described recently. Around the resting potential of STN
neurons, Cx-STN post-synaptic excitatory currents (EPSC) are mainly composed of AMPAR-mediated
currents with a small NMDA component [134,137]. Interestingly, it has been shown that the strength
of the Cx-STN inputs is under the control of DA and more specifically, of post-synaptic D5Rs which
depress AMPAR-mediated EPSC through a PKA-dependent intracellular pathway [137]. Another
study has also shown that pre-synaptic D2Rs modulate AMPA currents by decreasing glutamate
release [138]. Together, these data suggest that Cx-STN synaptic transmission is modulated by DA,
and hence, this pathway may be altered in PD. Indeed, it has been shown that, in DD rodents, Cx-STN
innervation is reduced [139–141] but the mechanisms underlying this loss of Cx-STN glutamatergic
inputs remain to be determined. It has been proposed that the alleviation of motor symptoms by M1
motor cortex deep brain stimulation (DBS) [142,143] relies on the restoration of Cx-STN functional
connectivity of the remaining Cx-STN afferent inputs [141].
5. The Substantia Nigra Pars Reticulata
5.1. Neuronal Diversity in the Substantia Nigra Pars Reticulata
Together with the EPN, the SNr is one of the output nuclei in the basal ganglia. Like other
BG nuclei, the SNr has been classically considered a homogeneous nucleus, and cell differences
were based more on topographical innervation patterns than on neuronal diversity. Although it is
well known that the main target of SNr is the thalamus [144], up to four neuron types have been
identified based on the axonal projection targets. Type I cells project specifically to the thalamus, type
II neurons target the thalamus, superior colliculus and pedundulopontine tegmental nucleus, type III
cells project to the periaqueductal gray matter and thalamus, and type IV neurons send projections to
the deep mesencephalic nucleus and the superior colliculus [145,146]. In addition to this long axonal
arborization, SNr neurons are also highly collateralized [145,147], and most neurons receive robust
inhibitory synaptic inputs even in the presence of strong activation [148,149].
In the SNr, GABAergic projection neurons are the largest cell population, but discrete clusters
of dopaminergic neurons are also present in the caudomedial region of the nucleus [150]. The
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majority of GABAergic neurons in the SNr express PV [151,152] and a small subset of cells express
calretinin [153,154], nitric oxide synthase, or acetylcholine transferase [150,155]. These cells differ in their
neurochemical content and their topographical and morphological profiles. Thus, in the rostrolateral
SNr, GABAergic cells are large and contain PV and nitric oxide synthase. In caudomedial positions,
most of them are small and express only PV, and in rostromedial portions, they are predominantly small
and contain either calretinin, nitric oxide synthase or PV [150]. As for receptor expression, the vast
majority of PV-positive neurons also display GABAA receptor α1 subunits and at least one (GABABR2)
of the heteromeric subunits of the GABAB receptor [156,157]. Moreover, cells with colocalized PV and
calbindin also express purinergic receptor P2 [158].
Neurochemical analysis clearly distinguishes three different classes of cellular content, but
electrophysiological characterization of GABAergic cells and correlation with the neurochemical profile
has yet to be fully developed. PV-positive cells have been associated with high firing frequency [159],
but this characteristic does not seem to be cell-specific. Indeed, calretinin-containing cells show
similar projection targets, local arborization, morphological, and electrophysiological characteristics
to PV-positive cells [160]. More recent studies describe four subtypes of GABAergic cells in the SNr,
whose electrophysiological profile is complex and varies according to the posture and movement of
the animal [161,162].
5.2. Ionic Conductances Underlying Pacemaking in Snr Neurons
Like other ESNs, SNr neurons are autonomously active. This regular spiking conveys an efficient
tonic inhibitory drive onto motor thalamic nuclei [163–165]. Repetitive AP generation in SNr neurons
is primarily supported by the subthreshold slowly inactivating NaV channels, while SK channels are
critical to maintain the precision of autonomous pacemaking in these neurons [18]. HCN are also
present in SNr cells but are not activated in the range of potential associated with pacemaking activity.
It has also been shown that leak conductances are critical for the maintenance of SNr neurons at
depolarized potential [166,167]. A molecular and electrophysiological study suggested that transient
receptor potential channel family (TRPC3) channels are expressed in SNr neurons and contribute to
their depolarized resting potential [167]. However, another study showed that spontaneous firing of
SNr neurons is unaffected after genetic deletion of these channels [166], questioning the participation
of these channels in the pacemaking of SNr neurons. This discrepancy can be explained by the lack of a
specific blocker of non-specific cationic channels used by Zhou and colleagues to show the involvement
of TRPC3 channels in the depolarized potential of SNr neurons. In addition, a more recent study has
discovered that SNr neurons express the sodium leak channel, NALCN, and that genetic deletion
of NALCN impairs spontaneous firing in these neurons [168]. Because the activity of NALCN is
strongly dependent upon glycolysis, alterations in this metabolic pathway can significantly impair
autonomous pacemaking in SNr neurons [166,168] and contributes to pathological activity of this
nucleus. As with other ESNs, Kv3-channels are essential for SNr neurons to fire APs at high frequency,
as they provide rapid repolarization of the membrane potential following AP depolarization [169]. An
extensive description of the ionic mechanisms governing SNr neurons excitability can be found in the
following review [170].
5.3. Dopamine Modulation of Intrinsic Excitability of Snr Neurons
Dopaminergic modulation of SNr is achieved through an unconventional release of DA by the
dendrites of SNc neurons (for review, see [171]), which constitutes an ultra-short dopaminergic pathway.
In situ hybridization and immunohistochemistry studies have shown that several DARs are expressed
in the SNr. The most intense labeling is for D1Rs, especially in striato-nigral terminals. D4Rs and D5Rs
are present in the SNr but mainly on perikarya [172–176], and D1/D5Rs have been found both on SNr
neurons and astrocytes [177]. D1-like agonists excite SNr neurons, and this modulation is mediated by
a PKA-dependent enhancement of the constitutively active TRPC3 channels, which depolarizes SNr
neurons [178]. Interestingly, this effect was mimicked by artificially elevating ambient DA levels, which
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supports its physiological and functional relevance [178]. In addition, acute blockade of D1-like and
D2-like receptors induces hyperpolarization of SNr neurons and a switch from tonic regular firing to
irregular or burst firing [47]. This pharmacological manipulation resembles the activity of SNr neurons
recorded in vivo in anesthetized [179–182] and awake [183] DD rodents. The cellular mechanisms
underlying the changes in rate and pattern of SNr under DD have not been explored ex vivo. It will
be of great interest to further investigate which intrinsic conductances of SNr neurons are directly
impacted by the loss of DA.
5.4. Alteration of Gabaergic and Glutamatergic Transmission in Snr Neurons in Experimental Parkinson’s
Disease Models
Anatomical studies have shown that single SNr neurons receive convergent afferents from dSPNs,
the GP and the STN (for review [184]), supporting a strong integrating function of this output nucleus
of the BG. Like in the GP, pallidal and striatal GABAergic inputs make symmetric synapses with the
soma/proximal dendrites and distal dendrites of SNr neurons, respectively [185–187]. In addition to
their subcellular locations, these two GABAergic synapses have also distinct properties. Striato-nigral
(STR-SNr) IPSCs exhibit STF, while pallido-nigral (GP-SNr) synapses display STD [188]. These two
synapses are also different regarding the pre-synaptic control exerted by DAR. GP-SNr synaptic
transmission is reduced by D4R activation [189,190] while STR-SNr GABA release is augmented by
D1Rs [189,191–193]. Because of its opposite action on STR-SNr and GP-SNr synapses, DA maintains a
certain equilibrium between somatic and dendritic inhibitory inputs received by SNr neurons, whose
precise function remains to be elucidated. The impact of DD on GP-SNr synaptic transmission is
unknown but has been investigated for STR-SNr synapses [194]. In their study, the authors report
that DD induces a strong increase in STR-SNr IPSC amplitude and show that dysfunctional GABAB
receptors and loss of presynaptic reduction of GABA release probability was responsible for this
augmented transmission [194].
The STN is the main provider of excitatory inputs to the SNr, and the properties of STN-SNr
synapses have been well characterized. Electrical stimulation of STN axons triggers monosynaptic
EPSCs [195,196], while the same type of stimulation delivered in the STN itself gives rise to
complex EPSCs [197,198], which are believed to be generated by the activation of STN local axon
collaterals [197,199]. Both D1Rs and D2Rs are present on STN-SNr synaptic terminals and activation
of D1Rs enhances while activation of D2Rs decreases STN-SNr EPSC amplitude [196]. On the other
hand, complex EPSCs which have been shown to promote burst-firing in SNr neurons [197,200] are
reduced by the activation of D2-like receptors [200]. Only long-term depression (LTD) has been
reported at STN-SNr. The induction of LTD requires post-synaptic D1R activation and is expressed
through NMDAR-dependent endocytosis of AMPARs, which depresses EPSC amplitude by almost
50% [195]. This mechanism represents a specific feature of this synapse compared to cortico-striatal
synapses [201], but like in the STR, DD completely abolishes STN-SNr LTD [195], supporting the
hypothesis that increased synaptic transmission at STN-SNr synapses contributes to pathological
activity of SNr neurons. DA-glutamate interplay dysfunctions at the post-synaptic density have been
suggested as critical determinants of major psychiatric disorders [202,203] and could be emphasized as
potential molecular targets at STN-SNr synapses to restore a normal level of activity of SNr neurons.
Overall, there is compelling evidence suggesting that both STR-SNr and STN-SNr synaptic
transmission strength is regulated by DA and is pathologically-enhanced in experimental PD.
6. The Entopeduncular Nucleus
6.1. Anatomical Organization and Cellular Diversity in the EPN
The EPN is, in addition to the SNr, the other output nucleus of the BG. Early anatomical studies
have suggested that the EPN is subdivided in rostral and caudal portions, with the former being
enriched in somatostatin-positive (SOM+) neurons and the latter being composed of PV-expressing
Cells 2019, 8, 1005 11 of 29
neurons [151,204,205]. More recently, a third neuronal population, negative for both SOM and PV, has
been described [206]. The proportion of these three populations has been estimated as 28% (PV+/SOM-),
46% (PV-/SOM+), and 25% (PV-/SOM-). Additional molecular profiling has confirmed the existence of
these three neuronal subtypes and has specified their molecular identity [207]. It has also been shown
that the EPN is organized in a PV-rich core and a PV-poor shell fashion [206]. Retrograde tracing studies
have demonstrated that SOM+ EPN neurons project to the lateral habenula (Lhb) [208,209], while
PV+ EPN neurons innervate the motor thalamus [151,208]. Furthermore, Lhb- and thalamic-projecting
EPN neurons are differentially innervated by subclasses of pallidal and striatal neurons [207,208].
EPN-thalamic neurons are innervated by PV+ GP neurons and matrix SPNs, while EPN-Lhb neurons
receive inputs from PV- GP neurons and striosome SPNs, suggesting that these two EPN cell types are
part of distinct functional networks. Indeed, it has been proposed that thalamic-projecting EPN neurons
control motor program selection, while Lhb-projecting EPN neurons participate in the evaluation of
the motor outcome [208].
6.2. Autonomous Pacemaking in EPN Neurons.
EPN neurons fire at a high rate in vivo both in anesthetized and awake rodents [210]. Like other
ESN, it is likely that this elevated discharge relies on intrinsic properties of EPN neurons. Indeed,
EPN neurons are spontaneously active ex vivo [211], but not much is known about the properties of
the channels responsible for autonomous pacemaking in these neurons, and DA modulation of their
excitability has never been investigated. Based on their firing pattern and properties ex vivo, two types
of EPN neurons have been described [211,212]. Type I EPN neurons are spontaneously active, generate
a sag upon membrane hyperpolarization, and generate a rebound-burst when hyperpolarizing current
injection ends, suggesting that they express HCN and CaV3-type calcium channels, respectively. Type
II EPN neurons are not autonomously active. They have low HCN channel expression and potassium
A-type currents, which generate a slow depolarizing ramp at the end of hyperpolarizing pulses of
currents [211]. Interestingly, most type I, but not type II, EPN neurons exhibit GABAergic IPSCs
upon electrical stimulation of the striatum [212], which suggests differential innervation of these two
cell types. Molecular and electrophysiological correlative studies would be required to determine if
Lhb-projecting and thalamic-projecting EPN neurons possess specific electrophysiological signatures.
To our knowledge, neither the modulation exerted by DA nor the direct consequences of DD on the
excitability of EPN neurons have yet been investigated.
6.3. Dopamine Modulation of Gabaergic and Glutamatergic Transmission in the EPN
Like the SNr, the EPN receive convergent inputs from the striatal direct-pathway, the GP, and the
STN [185,213]. Pallido-entopeduncular (GP-EPN) and striato-endopeduncular (STR-EPN) synapses
display the same properties as STR-SNr and GP-SNr synapses, i.e., STF and STD, respectively [214].
All DAR subtypes have been found in the EPN [215,216]. Their presynaptic distribution appears
to be very similar to that of the SNr: D2-like receptors are present on GP-EPN terminals, while D1Rs are
found on STR-EPN synapses [215,216]. The modulation exerted by DA on these two pathways seems
to also follow the principles described in the SNr, as D2-like receptors depress GP-EPN transmission
whereas STR-EPN inputs are potentiated by D1Rs [215,217]. The impact of DD on these synapses
has not been tested, but one may speculate that DD will facilitate GP-EPN synapses and depress the
STR-EPN synapses, therefore generating an imbalance between direct and indirect pathway GABAergic
inputs in the EPN.
The STN sends glutamatergic projections to the EPN [218]. The STN-EPN synapses display
spike-timing dependent LTD [219], which, like in the SNr, can be viewed as an adaptive mechanism to
regulate the impact of the STN on the output of the BG.
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7. Consequences of Cellular and Synaptic Dysfunctions for Abnormal Neural Dynamics in the
Basal Ganglia during Parkinson’s Disease
One critical aspect that remains to be addressed is defining the link between the different
molecular/synaptic alterations occurring after DA loss and the pathological BG activity recorded at the
network level. This lack of knowledge raises important questions that need to be assessed to better
understand how BG activity becomes dysfunctional in the DD state. In particular, it seems critical to
define if the synaptic modifications are the cause of the neuronal network dysfunction present in PD or
if it is the other way around. Also, being able to determine the respective contributions of the synaptic
vs. the network alterations to Parkinson’s motor symptoms might help in designing new therapeutic
strategies to target more precisely the pathophysiological process in PD. These are not trivial questions
to tackle, especially considering the difficulty of determining if these changes are truly pathogenic,
compensatory, or by-products of other (yet to be defined) neuronal changes. Another challenge facing
the field is the fact that the network abnormalities underlying the motor disturbances of PD are still
enigmatic. Indeed, while traditional views on the pathophysiological organization of BG circuits have
highlighted the contribution of firing rate alterations to explain the motor impairments present in
PD [8,220], other neuronal activities, such as changes in the firing pattern [182,221–224], or increases
in neuronal synchronization [77,78,225,226], have also been associated with the Parkinson’s disease
condition [227–229]. Whether these changes underlie the pathophysiology of PD is not known, but
their presence is positively correlated with the PD bradykinesia and rigidity score [230] and can be
used to distinguish the PD state [231]. Here, we will briefly review the principal neuronal network
changes occurring after DD, the arguments in favor or against their causative contribution to the
pathophysiology of PD, as well as how these network changes might be affected by the synaptic
alterations previously described in this review.
First, considering the firing rate modification, it has been shown that the loss of DA creates
an imbalance in activity in striatal projection neurons that leads to iSPN hyperactivity and dSPN
hypoactivity [73,232–234]. This increase in iSPN activity induces a cascade of firing rate changes
along the indirect pathway: notably decreased activity of GP neurons [14,71,235,236] and increased
activity of STN neurons [221,237]. These modifications lead to increased firing of the BG output nuclei
SNr/EPN [224,238], which translate into over-inhibition of the thalamo-cortical motor circuits [239].
The most compelling evidence in favor of a pathogenic contribution of the firing rate alterations comes
from studies that have used cell-type-specific optogenetic [9,240,241] or pharmacogenetics [134,242]
manipulations to reproduce the firing rate changes present in PD. In particular, specific excitation
of iSPNs induced a reduction of locomotion mimicking the PD akinetic state [9,134,242], whereas
activation of the dSPNs in PD model mice reduced the motor deficit and elicited locomotion [9]. In
addition, a direct link between the increase in SNr output activity and motor suppression has been
established consequently to iSPN opto-stimulation [240], thus supporting the view that BG outputs
exert an inhibitory influence on movement control [146]. The timing at which the firing rate of striatal
neurons is modified after DA loss is not known, but it is likely to be fast. Indeed, the expression of
the messenger RNA for c-fos, a marker of neuronal reactivity often used as a correlate of neuronal
activity [243], is increased in iSPNs 75 min after 6-OHDA injection. This timing parallels the DA
loss [244]. Therefore, it seems reasonable to expect that the firing rate modifications along the indirect
pathway are occurring before the synaptic reorganization (which might appear with longer time-scale
after DA loss). This assumption favors the idea that some of the synaptic changes observed in the
DD state might thus be corrective by nature, compensating for the abnormal firing rate activities
established in the indirect pathway. With this in mind, the selective loss of glutamatergic synapses
in iSPNs [245], the increased connectivity of striatal fast-spiking interneurons onto iSPNs [246] and
the increased number [133] and strength of GP synapses onto STN neurons [133,134] might represent
global homeostatic changes of the indirect pathway aiming to counterbalance the increased activity of
iSPNs. Similarly, the strong synaptic depression of the cortico-STN excitatory inputs present both in
rodents and monkey PD models [139,140] could also be an adaptive change to limit STN hyperactivity
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and, at the end-stage, the negative influence of BG output onto thalamo-cortical and brainstem
circuits. The apparent discrepancy between the functional restoration of the Cx-STN pathway by
motor cortex DBS (see Section 4.4) and an adaptive reduction of this pathway to counteract STN
hyperactivity can be explain if motor cortex DBS acts by breaking pathological activity and promoting
corticofugal [247] information transfer rather than simply increasing Cx-STN synaptic transmission.
However, despite all the experimental evidence arguing for an important contribution of BG overall
firing rate modification in experimental PD, it is still unknown if they represent the sole pathogenic
cause of Parkinsonism [248–250]. Additionally, many experimental findings have directly challenged
the predictions of the rate model. For example, while recordings in MPTP-treated monkeys have
clearly established STN firing hyperactivity [221,235], changes in striatal firing activity as described by
the rate model have been more conflicting. Indeed, while one study described a profound increase in
striatal neuronal firing [251], another reported no change [235]. In addition, recordings in DD mice
have shown a reduction in the autonomous properties of STN neurons which, when restored using
chemogenetic excitation of STN, improves motor dysfunction in DD mice [125]. Considering the fact
that motor recovery in PD is classically obtained using suppression [252] or reduction [238] of STN
neuronal firing, these results were totally unexpected, and in contrast with the motor-suppressing
effect predicted by the rate model when STN increase their activity. Another piece of experimental
evidence that challenges the rate model is the fact that SNr firing output in DD mice is hypoactive and
not hyperactive [183]. Taken together, the direction of the firing rate changes in various nodes of BG
circuits might not be consistently present across different animal models of PD (i.e., rats vs. mice vs.
monkeys), thus raising the possibility that other neuronal changes might more reliably contribute to
the motor dysfunction of PD.
Abnormal expression of synchronized oscillatory activity in the beta frequency band (12-35
Hz) has been one of the most prominent neuronal changes consistently detected in PD patients and
has been related to akinesia/bradykinesia syndromes in PD [253,254]. Accordingly, a correlation
between the level of beta oscillation expression and the motor deficit has been described in the
off-medicated state of PD [255] (but see [256]). In addition, imposing abnormal beta synchronization
through external stimulation at beta frequency slows down movements both in healthy [257] and
PD subjects [258], which suggests a pathogenic role (although this stimulation protocol likely altered
the level of neuronal firing, which was not accounted for in the motor perturbation). What are the
neuronal circuits generating this abnormal beta synchronization? In theory, any network with delayed
negative feedback properties can generate oscillatory activity [259], and because the organization
of the BG is principally composed of parallel feedback loops, many BG circuits could potentially
generate beta oscillations [260–262]. It was first proposed that the abnormal BG synchronization is
an emergent property of the GP-STN network [263], but this work was performed in organotypic
culture and so far, there is no in vivo evidence that the GP-STN network could sustain synchronized
rhythmic activity without the cortex [222,264]. Other proposed circuit generators of beta oscillations
are the cortex [265], the striatum [266], the STR-GP network [267], and the hyperdirect loop [268]. One
influential hypothesis suggests that beta oscillations are generated at the cortex at physiological levels,
which propagate in BG circuits through the hyperdirect pathway where they are abnormally amplified
by the reciprocally-connected GP-STN microcircuits [265,269,270]. There is indeed a strong rationale to
suggest that the GP-STN network is involved in the maintenance and the propagation of oscillatory
activity both in vivo and ex vivo [13,14,71,271,272]. Nonetheless, the specific contribution of these
different circuit elements has never been tested with optogenetic tools that are reversible and offer high
temporal resolution. One aspect to consider is the timing at which abnormal beta synchronization is
generated after the DA loss, as it reveals important features regarding its contribution and interaction
with the firing rate or synaptic modifications. Interestingly, beta oscillations are not detected in PD
rat models until >4 days after the lesion and reach a plateau of expression after 10 days. This slow
time-scale of generation contrasts with the fast motor deficits that appear within hours following the
loss or the blockage of DA transmission [237,273,274]. Similarly, monkeys and rats present Parkinson’s
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associated motor symptoms following chronic MPTP or 6-OHDA treatment before the emergence of
BG synchronous oscillatory activity [250,275]. Taken together, this suggests that beta synchronized
oscillations might arise through long-term adaptive changes that are slower than the changes in firing
rate, but which could parallel the timing of the synaptic alterations. This potentially highlights the
relationship between these two kinds of activity, but whether one is the consequence of the other
is currently not known. Similarly, the link between the firing rate modifications and the change in
neuronal synchronization has never been investigated. We propose here the hypothesis that the GP
firing rate alterations in PD trigger maladaptive modifications that favor GP neuronal synchronization.
Indeed, in a normal animal, the firing of GP neurons is principally governed by their autonomous
pacemaker properties, which are different across neurons due to variability in channel density [53,79].
Active decorrelation mechanisms caused by GP neurons’ intrinsic properties and mutual inhibition
through axon collaterals prevent neuronal synchronization in normal conditions [226,276]. This
indicates that the intra-GP GABAergic control in normal conditions is mainly achieved by GP neurons.
In contrast, the loss of DA in PD, which causes the increase in iSPN firing, operates a switch in the
GP GABAergic control from intrinsic (i.e., GP) to extrinsic (i.e., STR) sources. This change of GABA
transmission is certainly at the origin of maladaptive changes at the molecular and synaptic level
that favor the generation of synchronized oscillatory activity in GP neurons. Because of the critical
dichotomous organization of GP neurons into prototypic and arkypallidal neurons [14], this abnormal
oscillatory activity can then propagate to the whole BG circuit. In this scheme, the abnormal network
synchronization is caused by maladaptive changes occurring at the cellular and synaptic levels and
is a consequence of the firing rate perturbation in the indirect pathway. It is important to mention
though that this abnormal beta synchronization has been detected in PD animal models, such as
6-OHDA-lesioned rats [237,247,277–279] and MPTP-treated monkeys [235,280], but not in 6-OHDA or
α-synuclein mice [183,281], which raises the question of their contribution to the pathophysiology of
PD. Indeed, future studies will have to precisely define the specific behavioural contributions of the
different neuronal activities and how they impact the motor symptoms of PD.
STN or GPi DBS is highly effective to alleviate PD motor symptoms and it is widely thought
that DBS achieves its therapeutic action by disrupting pathological oscillatory activity in the motor
cortex/BG loops [282,283]. Considering the complex anatomical connectivity of the BG and the possible
concomitant local and distant effects of STN-DBS [247,284–286], the mechanisms through which high
frequency stimulation breaks down pathological activity and restores motor function remains highly
debated. Because axons are known to be more responsive to electrical stimulation than cell bodies [287]
and that globally ESN synapses are pathologically-enhanced in PD models one may speculate that
STN-DBS has a stronger impact on synaptic transmission and neurotransmitter release rather than
on neuronal excitability, which allow them to re-establish information transfer within the BG and
execution of motor programs. In addition to what has been done already [142], the future development
of optogenitically-based DBS protocols will certainly help to better understand where in the network
and by which precise mechanism(s) STN-DBS restores motor function in PD.
8. Concluding Remarks
In this review of the literature, we have highlighted that every ESN of the BG receives a functional
DA innervation that controls both the post-synaptic excitability as well as the strength of their afferent
synaptic inputs. In PD, extrastriatal hypodopaminergy provoked by the loss of SNc neurons must
participate, in addition to the alterations described in the striatum, in the pathophysiological activity
of the BG network. According to all the evidence accumulated over the past decades, we propose that
DA loss induces an imbalance between ESN neuron intrinsic excitability and ESN synapses, in favor of
the latter. Autonomous pacemaking is reduced in all ESN while synaptic transmission is enhanced,
leading to a switch from intrinsically-driven oscillatory activity in ESN to a synaptically-driven pattern
of activity, which promotes hypersynchronous oscillatory activity in the BG network in PD (Figure 4B).
Cells 2019, 8, 1005 15 of 29
Cells 2019, 8, 1005 15 of 31 
 
 
Figure 4. Cellular and synaptic alterations in the ESN in experimental PD. (A) Summary diagram of 
the main modifications in cellular excitability and synaptic transmission observed in the BG network 
under DA-depleted conditions. Black arrows indicate increase or decrease in synaptic transmission 
or intrinsic excitability (represented by black APs). Astr.: astrocyte involvement in GABAergic 
dysfunction in GP. GABAergic and glutamatergic projections and nuclei are depicted in blue and 
red, respectively. Loss of SNc DA neurons is represented by the dashed purple circle. (B) Schematic 
illustrating the modification in the balance between intrinsic neuronal excitability and synaptic 
strength in ESN as a function of the levels of DA. 
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